S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
S&P 500   4,228.48 (-1.29%)
DOW   33,706.74 (-0.86%)
QQQ   322.86 (-1.95%)
AAPL   171.52 (-1.51%)
MSFT   286.15 (-1.39%)
META   167.96 (-3.84%)
GOOGL   117.21 (-2.46%)
AMZN   138.23 (-2.86%)
TSLA   890.00 (-2.05%)
NVDA   178.49 (-4.92%)
NIO   19.05 (-4.32%)
BABA   89.63 (-1.22%)
AMD   95.95 (-4.47%)
T   18.43 (+0.00%)
MU   60.51 (-3.92%)
CGC   3.82 (+0.26%)
F   15.88 (-1.67%)
GE   77.72 (-1.88%)
DIS   120.14 (-2.06%)
AMC   18.02 (-6.58%)
PYPL   96.56 (-3.30%)
PFE   49.15 (+1.17%)
NFLX   241.16 (-1.64%)
NYSE:MDC

M.D.C. - MDC Stock Forecast, Price & News

$34.17
-0.72 (-2.06%)
(As of 08/19/2022 12:00 AM ET)
Add
Compare
Today's Range
$34.05
$34.55
50-Day Range
$28.26
$37.30
52-Week Range
$27.83
$56.53
Volume
648,646 shs
Average Volume
595,873 shs
Market Capitalization
$2.43 billion
P/E Ratio
3.88
Dividend Yield
5.73%
Price Target
$47.33

M.D.C. MarketRank™ Forecast

Analyst Rating
Hold
2.25 Rating Score
Upside/​Downside
38.5% Upside
$47.33 Price Target
Short Interest
Bearish
5.45% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
N/A
News Sentiment
0.26mentions of M.D.C. in the last 14 days
Based on 19 Articles This Week
Insider Trading
Selling Shares
$1.41 M Sold Last Quarter
Proj. Earnings Growth
-21.47%
From $9.64 to $7.57 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.73 out of 5 stars

Construction Sector

13th out of 105 stocks

Operative Builders Industry

4th out of 16 stocks

MDC stock logo

About M.D.C. (NYSE:MDC) Stock

M.D.C. Holdings, Inc., through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name. The company conducts its homebuilding operations in Arizona, California, Nevada, New Mexico, Oregon, Texas, Washington, Colorado, Idaho, Utah, Maryland, Pennsylvania, Virginia, Tennessee, and Florida. Its financial services operations comprise originating mortgage loans primarily for homebuyers; providing insurance coverage primarily to its homebuilding subsidiaries and subcontractors for homes sold by its homebuilding subsidiaries, and for work performed in completed subdivisions; acting as a re-insurer on the claims; selling third-party personal property and casualty insurance products to homebuyers; and offering title agency services to homebuilding subsidiaries and customers in Colorado, Florida, Maryland, Nevada, and Virginia. M.D.C. Holdings, Inc. was founded in 1972 and is headquartered in Denver, Colorado.

M.D.C. Stock Down 1.2 %

MDC traded down $0.42 on Friday, reaching $34.47. The company's stock had a trading volume of 677 shares, compared to its average volume of 502,696. The stock has a 50 day moving average of $34.10 and a two-hundred day moving average of $37.84. The company has a quick ratio of 1.46, a current ratio of 7.31 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $2.45 billion, a price-to-earnings ratio of 3.96 and a beta of 1.37. M.D.C. has a fifty-two week low of $27.83 and a fifty-two week high of $56.53.

M.D.C. (NYSE:MDC - Get Rating) last posted its quarterly earnings data on Thursday, July 28th. The construction company reported $2.59 earnings per share for the quarter, beating the consensus estimate of $2.50 by $0.09. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.43 billion. M.D.C. had a return on equity of 24.31% and a net margin of 11.71%. The company's revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.11 earnings per share. As a group, analysts forecast that M.D.C. will post 9.64 EPS for the current fiscal year.

M.D.C. Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 24th. Stockholders of record on Wednesday, August 10th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 5.80%. The ex-dividend date of this dividend is Tuesday, August 9th. M.D.C.'s dividend payout ratio (DPR) is presently 22.70%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on MDC. JPMorgan Chase & Co. cut their target price on shares of M.D.C. from $40.50 to $38.00 and set a "neutral" rating on the stock in a research note on Tuesday, July 12th. Wells Fargo & Company lowered shares of M.D.C. from an "equal weight" rating to an "underweight" rating and set a $27.00 target price on the stock. in a research note on Friday, June 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, M.D.C. currently has a consensus rating of "Hold" and a consensus price target of $47.33.

Insider Transactions at M.D.C.

In other news, Director Raymond T. Baker sold 33,067 shares of the company's stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $35.59, for a total transaction of $1,176,854.53. Following the completion of the sale, the director now owns 40,187 shares in the company, valued at $1,430,255.33. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director David Siegel sold 6,500 shares of the firm's stock in a transaction on Monday, August 15th. The stock was sold at an average price of $35.40, for a total value of $230,100.00. Following the completion of the transaction, the director now owns 16,519 shares in the company, valued at $584,772.60. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Raymond T. Baker sold 33,067 shares of the firm's stock in a transaction on Friday, July 29th. The shares were sold at an average price of $35.59, for a total value of $1,176,854.53. Following the completion of the transaction, the director now owns 40,187 shares of the company's stock, valued at approximately $1,430,255.33. The disclosure for this sale can be found here. Company insiders own 24.20% of the company's stock.

Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter.

MDC Stock News Headlines

Richmond American Debuts New Neighborhoods in Aurora
See More Headlines
Receive MDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for M.D.C. and its competitors with MarketBeat's FREE daily newsletter.

MDC Company Calendar

Ex-Dividend for 5/25 Dividend
5/10/2022
Dividend Payable
5/25/2022
Last Earnings
7/28/2022
Ex-Dividend for 8/24 Dividend
8/09/2022
Today
8/19/2022
Dividend Payable
8/24/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Operative builders
Sub-Industry
Homebuilding
CUSIP
55267610
Employees
2,080
Year Founded
1972

Price Target and Rating

Average Stock Price Forecast
$47.33
High Stock Price Forecast
$77.00
Low Stock Price Forecast
$27.00
Forecasted Upside/Downside
+38.5%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Net Income
$573.66 million
Pretax Margin
15.62%

Debt

Sales & Book Value

Annual Sales
$5.25 billion
Cash Flow
$8.40 per share
Book Value
$40.39 per share

Miscellaneous

Free Float
53,936,000
Market Cap
$2.43 billion
Optionable
Optionable
Beta
1.37

Social Links


Key Executives

  • Mr. Larry A. Mizel (Age 79)
    Exec. Chairman
    Comp: $9.08M
  • Mr. David D. Mandarich (Age 74)
    Pres, CEO & Director
    Comp: $7.01M
  • Mr. Robert Nathaniel MartinMr. Robert Nathaniel Martin (Age 43)
    Sr. VP, CFO & Principal Accounting Officer
    Comp: $2.36M
  • Ms. Leslie B. Fox (Age 63)
    Consultant
    Comp: $251k
  • Mr. Ryan Berry
    Director of Corp. Fin. & Assistant Treasurer
  • Mr. Kelly Taga
    Chief Information Officer & VP
  • Ms. Krista Montgomery
    Sr. VP & Chief HR Officer
  • Mr. Jack Gallagher
    Regional Pres of Maryland, Virginia & Florida - Richmond American Homes Corp.
  • Ms. Dawn Huth
    Sr. VP of National Fin. - Richmond American Homes
  • Ms. Natasha Gandhi
    Sr. Division Pres of South & Central Colorado













MDC Stock - Frequently Asked Questions

Should I buy or sell M.D.C. stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last year. There are currently 1 sell rating, 2 hold ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MDC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDC, but not buy additional shares or sell existing shares.
View MDC analyst ratings
or view top-rated stocks.

What is M.D.C.'s stock price forecast for 2022?

4 Wall Street analysts have issued 12-month target prices for M.D.C.'s stock. Their MDC share price forecasts range from $27.00 to $77.00. On average, they anticipate the company's share price to reach $47.33 in the next year. This suggests a possible upside of 38.5% from the stock's current price.
View analysts price targets for MDC
or view top-rated stocks among Wall Street analysts.

How have MDC shares performed in 2022?

M.D.C.'s stock was trading at $55.83 at the beginning of 2022. Since then, MDC shares have decreased by 38.8% and is now trading at $34.17.
View the best growth stocks for 2022 here
.

Are investors shorting M.D.C.?

M.D.C. saw a increase in short interest in July. As of July 31st, there was short interest totaling 3,090,000 shares, an increase of 31.5% from the July 15th total of 2,350,000 shares. Based on an average daily volume of 593,400 shares, the days-to-cover ratio is currently 5.2 days. Approximately 5.5% of the shares of the stock are sold short.
View M.D.C.'s Short Interest
.

When is M.D.C.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our MDC earnings forecast
.

How were M.D.C.'s earnings last quarter?

M.D.C. Holdings, Inc. (NYSE:MDC) issued its quarterly earnings data on Thursday, July, 28th. The construction company reported $2.59 EPS for the quarter, beating analysts' consensus estimates of $2.50 by $0.09. The construction company earned $1.45 billion during the quarter, compared to analyst estimates of $1.43 billion. M.D.C. had a trailing twelve-month return on equity of 24.31% and a net margin of 11.71%. The business's revenue was up 6.1% on a year-over-year basis. During the same period last year, the company posted $2.11 EPS.

How often does M.D.C. pay dividends? What is the dividend yield for M.D.C.?

M.D.C. declared a quarterly dividend on Thursday, July 28th. Investors of record on Wednesday, August 10th will be given a dividend of $0.50 per share on Wednesday, August 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 5.85%. The ex-dividend date of this dividend is Tuesday, August 9th.
Read our dividend analysis for MDC
.

Is M.D.C. a good dividend stock?

M.D.C. (NYSE:MDC) pays an annual dividend of $2.00 per share and currently has a dividend yield of 5.73%. MDC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.70%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MDC will have a dividend payout ratio of 26.42% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDC.

What other stocks do shareholders of M.D.C. own?

Based on aggregate information from My MarketBeat watchlists, some companies that other M.D.C. investors own include Alibaba Group (BABA), Verizon Communications (VZ), Procter & Gamble (PG), Intel (INTC), NVIDIA (NVDA), Cisco Systems (CSCO), Home Depot (HD), Johnson & Johnson (JNJ), Pfizer (PFE) and QUALCOMM (QCOM).

What is M.D.C.'s stock symbol?

M.D.C. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDC."

Who are M.D.C.'s major shareholders?

M.D.C.'s stock is owned by a number of retail and institutional investors. Top institutional investors include State Street Corp (3.48%), Hamlin Capital Management LLC (2.19%), Principal Financial Group Inc. (2.05%), Miller Howard Investments Inc. NY (1.24%), FMR LLC (0.94%) and Northern Trust Corp (0.87%). Insiders that own company stock include David D Mandarich, David E Blackford, David Siegel, Herbert T Buchwald, Jean-Frederic Viret, Larry A Mizel, Leslie B Fox, Michael A Berman, Paris G Reece III, Raymond T Baker, Robert Nathaniel Martin and Staci M Woolsey.
View institutional ownership trends
.

How do I buy shares of M.D.C.?

Shares of MDC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is M.D.C.'s stock price today?

One share of MDC stock can currently be purchased for approximately $34.17.

How much money does M.D.C. make?

M.D.C. (NYSE:MDC) has a market capitalization of $2.43 billion and generates $5.25 billion in revenue each year. The construction company earns $573.66 million in net income (profit) each year or $8.81 on an earnings per share basis.

How many employees does M.D.C. have?

The company employs 2,080 workers across the globe.

When was M.D.C. founded?

M.D.C. was founded in 1972.

How can I contact M.D.C.?

M.D.C.'s mailing address is 4350 S MONACO STREET SUITE 500, DENVER CO, 80237. The official website for the company is www.mdcholdings.com. The construction company can be reached via phone at (303) 773-1100, via email at ir@mdch.com, or via fax at 303-771-3461.

This page (NYSE:MDC) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.